Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03290300 · ClinicalTrials.gov registry record
Quality of Life Impact of Nasal Airway Treatment With Aerin Medical Device
A clinical trial, sponsored by Aerin Medical.
- Completed
- Registry status
- 39
- Enrollment target
NCT03290300: Completed study, sponsored by Aerin Medical.
NCT03290300 is a clinical trial that has completed, run by Aerin Medical. The registered enrollment target is 39 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03290300 has completed, sponsored by Aerin Medical.
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
Study Summary
Evaluation of long-term (5-year) quality of life after nasal airway obstruction treatment with the Aerin Vivaer Stylus
Primary Outcome
Mean change in Nasal Obstruction Symptom Evaluation (NOSE) score from baseline. The NOSE scale ranges from 0 to 100, so a maximum change from baseline would be 100 points. A positive number reported for the change from baseline indicates an improved outcome.
Interventions
- DEVICE Vivaer Stylus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2017-10-30 |
| Est. Completion | 2022-07-09 |
What the finished NCT03290300 record still lists
NCT03290300 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 39 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Vivaer Stylus is the first listed.
NCT03290300 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03290300 about?
NCT03290300 is a clinical study titled "Quality of Life Impact of Nasal Airway Treatment With Aerin Medical Device". Evaluation of long-term (5-year) quality of life after nasal airway obstruction treatment with the Aerin Vivaer Stylus
What is the current status of trial NCT03290300?
This trial is currently completed. The enrollment target is 39 participants. The study started on 2017-10-30. Estimated completion is 2022-07-09.
What interventions are being tested in trial NCT03290300?
The interventions under investigation include: Vivaer Stylus (DEVICE).
Who is sponsoring clinical trial NCT03290300?
This trial is sponsored by Aerin Medical, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI